JAZZ

Jazz Pharmaceuticals plc Press Releases

$136.155
*  
0.055
 negative 
0.04%
Get JAZZ Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pharma Stocks on our Radar -- Research on AVANIR Pharma, Zoetis, Salix Pharma, and Jazz Pharma
4/10/2014 12:31:00 PM - PR Newswire

Clinical Study Initiations, Stock Price Updates, and Strategic Agreements - Analyst Notes on Ariad, Jazz, Intercept, Community Health, and United Technologies
4/2/2014 8:00:00 AM - PR Newswire

Jazz Pharmaceuticals And Gentium Announce European Commercial Launch Of First Approved Life-Saving Treatment For Severe Hepatic Veno-Occlusive Disease
3/31/2014 8:00:00 AM - PR Newswire

Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March
2/26/2014 6:00:00 PM - PR Newswire

Jazz Pharmaceuticals Announces Management Change
2/25/2014 4:07:00 PM - PR Newswire

Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2013 Financial Results
2/25/2014 4:05:00 PM - PR Newswire

Jazz Pharmaceuticals plc Completes Tender Offer For Gentium S.p.A. Shares
2/21/2014 8:00:00 AM - PR Newswire

Jazz Pharmaceuticals to Report 2013 Fourth Quarter and Full Year Financial Results on February 25, 2014
2/11/2014 4:07:00 PM - PR Newswire

Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension
2/11/2014 4:05:00 PM - PR Newswire

Jazz Pharmaceuticals Breaks Ground On New Manufacturing And Development Facility In Ireland
2/10/2014 8:05:00 AM - PR Newswire

CHD Bioscience Appoints Dr. Catherine Angell Sohn to its Board of Directors
2/3/2014 9:00:00 AM - PR Newswire

Jazz Pharmaceuticals plc Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares
1/23/2014 2:24:00 AM - PR Newswire